TAS-303

· Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TAS-303, covering 2016-08-10 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence [Phase 2]